2Garcla H M, Garcfa S D. Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents[ J]. Rev Argent Microbio1,2006,38 ( 1 ) :9-12.
3Strus M, Brzychczy W M, Kucharska A, et al. Inhibitory activity of vaginal Lactobacillus bacteria on yeasts causing vulvovaginal candidiasis [ J ]. Med Dosw Mikrobio1,2005,57 ( 1 ) :7-17.
4Jeavons H S. Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus [ J ]. J Obstet Gynecol Neonatal Nurs ,2003,32 ( 3 ) :287-296.
5Martinez R C, Seney S L, Summers K L, et al. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation[ J]. Microbiol Immuno1,2009,53 (9) :487-95.
6McClelland R S, Richardson B A, Hassan W M, et al. Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis[ J]. J Infect Dis.2009,199(12) :1883-1890.
7谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
8Donati L, Di Vieo A, Nucei M, et al. Vaginal microbial flora and out- come of pregnancy[ J]. Archives of gynecology and Obstetrics,2010, 281 (4) :589 -600.
9Dulay AT, Buhimschi CS, Zhao GM, et al. Soluble TLR2 is present in human amniotic fluid and modulates the intra-amniotic inflammatory response to infection [ J ]. Journal of immunology, 2009,182 ( 11 ) : 7244 - 7253.
